Background: Metabolic syndrome (MetS) is more common in HIV-infected adults and
children than in the general population. Adipocytokines and inflammatory markers may …

Background: Metabolic syndrome (MetS) is considered an independent risk factor for
developing cardiovascular disease. It is well known that the prevalence of metabolic …

Background In human immunodeficiency virus (HIV)-infected patients on combination
antiretroviral therapy (cART), lipodystrophy shares many similarities with metabolic …

Background Lipodystrophy is common in HIV-infected patients receiving protease inhibitors
(PIs), stavudine, and zidovudine. Adipocytokines may be altered in lipodystrophy. We …

Metabolic syndrome HOMA a 0.36 (0.25; 0.59) 0.26 (0.10; 0.32) 0.208 0.8 (0.4; 1.9) 0.046
0.003 Insulin (pg/mL) 79.5 (63.2; 136.1) 54.03 (48.5; 72) 0.131 164.2 (112.7; 356.4) 0.026 …

Objective The aim of the study was to evaluate the evolution of plasma adipokines and
lipodystrophy in protease inhibitor‐naïve vertically HIV‐infected children on highly active …

The objective of this study was to investigate the factors underlying the development of
metabolic syndrome (MetS) in HIV-infected patients. Two hundred and sixty-six clinical …

We read with interest the review of Calza et al. in which the authors described how highly
active antiretroviral therapy (HAART) has increased the rate of metabolic abnormalities …

Background Successful antiretroviral therapy (ART) has dramatically reduced mortality
among HIV-infected children. However, there is growing concern about long-term effects …

Purpose HIV/HAART associated metabolic syndrome (HAMS) seems to result from direct
influence of HIV, adverse effects of combined antiretroviral therapy (cART) and individual …